British scientists have made a potentially important discovery related to dementia and Alzheimer’s disease that could pave the way for the development of drugs to treat the conditions.In a paper ...

When Apellis Pharmaceuticals (APLS) secured FDA approval for EMPAVELI in C3 glomerulopathy and IC-MPGN last summer, the stock was trading near $28. Today it sits at $19.96, down 31% over the past year ...

The study found that the benefits of statins were also seen in people who were considered to have a low risk of developing ...

Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pediatric Disease Designation SEATTLE, /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa ...

The rise of China, the buzz around AI, challenging global market dynamics, the recent surge in dealmaking and exciting new ...

Many of these advances are the result of decades of work and clinical trials. Since the mid-1990s, the American Cancer ...

Translational medicine researchers used the Mimetas® human kidney glomerulus-on-a-chip to investigate potential pharmaceutical interventions for patients with a severe kidney disease called focal ...

Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...

Learn to manage anxiety in advanced Parkinson's with treatments like therapy, medication, lifestyle changes, and more to ...

Treating weight loss that way overlooks the real biological and medical factors involved, which can prevent people from ...

IgA nephropathy is a type of kidney disease that is typically treated with various medicines and lifestyle changes. Learn more about IgA nephropathy treatment here.

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation – a ...